Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Controversy in the diagnosis and treatment of hemodynamically significant patent ductus arteriosus in preterm infants

  • Sung, Se In (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • Received : 2019.05.22
  • Accepted : 2019.06.17
  • Published : 2019.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Lee JA. Practice for preterm patent ductus arteriosus; focusing on the hemodynamic significance and the impact on the neonatal outcomes. Korean J Pediatr 2019;62:245-51. https://doi.org/10.3345/kjp.2018.07213
  2. Bose CL, Laughon MM. Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed 2007;92:F498-502. https://doi.org/10.1136/adc.2005.092734
  3. Skinner J. Diagnosis of patent ductus arteriosus. Semin Neonatol 2001;6:49-61. https://doi.org/10.1053/siny.2000.0037
  4. de Freitas Martins F, Ibarra Rios D, F Resende MH, Javed H, Weisz D, Jain A, et al. Relationship of patent ductus arteriosus size to echocardiographic markers of shunt volume. J Pediatr 2018;202:50-55.e3. https://doi.org/10.1016/j.jpeds.2018.06.045
  5. El-Khuffash A, James AT, Corcoran JD, Dicker P, Franklin O, Elsayed YN, et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr 2015;167:1354-61.e2. https://doi.org/10.1016/j.jpeds.2015.09.028
  6. Chock VY, Rose LA, Mante JV, Punn R. Near-infrared spectroscopy for detection of a significant patent ductus arteriosus. Pediatr Res 2016;80:675-80. https://doi.org/10.1038/pr.2016.148
  7. Dagle JM, Ryckman KK, Spracklen CN, Momany AM, Cotten CM, Levy J, et al. Genetic variants associated with patent ductus arteriosus in extremely preterm infants. J Perinatol 2019;39:401-8. https://doi.org/10.1038/s41372-018-0285-6
  8. Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, et al. PDA-TOLERATE Trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr 2019;205:41-8.e6. https://doi.org/10.1016/j.jpeds.2018.09.012
  9. Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, Lindqvist J, et al. Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320). J Perinatol 2019;39:599-607. https://doi.org/10.1038/s41372-019-0347-4

Cited by

  1. Risk Factors and Neonatal Outcomes of Patent Ductus Arteriosus Ligation in Preterm Infants in a Single Center over 6 Years vol.31, pp.4, 2020, https://doi.org/10.14734/pn.2020.31.4.191
  2. Relationship between Gentamicin Administration and Ductal Patency in Very Low Birth Weight Infants vol.16, 2019, https://doi.org/10.2174/1574884716666210603110412
  3. Open or closed: Changes in ductus arteriosus flow patterns at birth using 4D flow MRI in newborn piglets vol.9, pp.17, 2019, https://doi.org/10.14814/phy2.14999